Rocket Lab USA, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RKLB research report →
Range $80 – $132
Price Chart
About the company
Headquartered in Long Beach, California, Rocket Lab USA, Inc. is a prominent aerospace firm established in 2006. This company delivers a comprehensive suite of space-related services and hardware, primarily catering to the space and defense industries.
- CEO
- Sir Peter Beck
- IPO
- 2020
- Employees
- 2,600
- HQ
- Long Beach, CA, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a long-term corrective regime, still well below its 200-day moving average and far from the 52-week high. The setup is a high-beta recovery story, with price action trying to stabilize after a sharp drawdown from the prior peak.
Street sentiment stays constructive: consensus is Buy with a $105.17 target, above the last close. Recent changes show mostly reiterated positive ratings, though several firms trimmed targets after the Neutron launch slipped to 2027, keeping upside tied to execution.
Expect another loss, with next-quarter EPS estimated at -$0.05 and full-year 2027 EPS still projected negative at -$0.04167. Shareholders should watch whether revenue growth and margin progress can offset launch-timing pressure and keep the beat pattern intact after 3 of the last 7 quarters.
Recent insider activity leans negative on the discretionary side, led by CFO Adam Spice’s repeated open-market sales in September and October. The officer-level selling outweighs the single director gift, while the M-Exempt entries look like award or vesting-related noise rather than conviction buying.
Profitability is still negative, but the top line is growing fast: revenue rose 62% year over year. Gross margin is 37.3%, while operating margin remains -24.57% and free cash flow was slightly negative at -$9.236 million, showing scale is improving before earnings power.
RKLB sits in the premium-growth end of aerospace and defense, where investors pay for launch cadence and Neutron optionality rather than current profits. The valuation remains rich versus the sector, with a negative P/E and a market cap that already discounts meaningful execution.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $32.21B
- P/E
- -189.96
- Fwd P/E
- 208.54
- PEG
- -3.76
- P/S
- 40.93
- P/B
- 9.48
- EV/EBITDA
- -241.63
- Div Yield
- 0.00%
- Gross Margin
- 37.26%
- Op Margin
- -29.06%
- Net Margin
- -21.51%
- ROE
- -7.56%
- ROIC
- -5.27%
Latest fiscal year · YoY change
- Revenue
- $601.80M+38.0%
- Gross Profit
- $207.18M+78.4%
- Op Income
- $-228,838,000
- Net Income
- $-198,209,000-4.2%
- EPS
- $-0.37+2.6%
- OCF Growth
- -238.6%
- FCF Growth
- -177.5%
- 52W High
- $151.00
- 52W Low
- $37.57
- 50D MA
- $66.34
- 200D MA
- $80.59
- Beta
- 2.61
- RSI (14)
- 33
- Avg Volume
- 19.53M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Rocket Lab posted record Q2 revenue, raised its strategic profile with major new contract wins and acquisitions, and said Neutron is still tracking toward first flight despite elevated cash burn.· August 10, 2026
- Q2 revenue hit a record $234 million, up 62% year over year and 16.8% sequentially.
- Space Systems led growth at $189.5 million, while Launch Services was $44.6 million and mixed lower because of revenue timing in HASTE versus Electron.
- Backlog ended at about $2.36 billion, with management citing more than $1 billion of new contracts signed across Q2 and post-quarter.
- Rocket Lab announced or closed several strategic moves: Mynaric and Motiv closed, and it is pursuing Iridium to add space applications and recurring revenue.
- Neutron development remains on track for Q4 2026 pad delivery, but management said the first launch window is narrowing and cash needs stay elevated.
Second-quarter 2026 revenue was a record $234 million, up 62% year over year and 16.8% sequentially. Space Systems revenue was $189.5 million, up 38.6% sequentially, and Launch Services revenue was $44.6 million, down 30% sequentially due to mix and accounting timing. GAAP gross margin was 36.1% and non-GAAP gross margin was 41.5%, both above guidance; GAAP EPS was a loss of $0.08 per share versus a loss of $0.07 in Q1. GAAP operating cash flow was a use of $84.1 million, non-GAAP free cash flow was a use of $110.1 million, and cash, cash equivalents, restricted cash and marketable securities ended at roughly $2.4 billion. Backlog ended Q2 at about $2.36 billion, with about 45.5% expected to convert to revenue within 12 months. For Q3 2026, management guided revenue to $250 million to $265 million, GAAP gross margin to 29% to 31%, non-GAAP gross margin to 35% to 37%, GAAP operating expenses to $143 million to $149 million, non-GAAP operating expenses to $121 million to $127 million, adjusted EBITDA loss to $17 million to $23 million, and net interest income to $21 million.
Peter Beck framed the quarter as an inflection point for Rocket Lab’s transition from launch-and-hardware into a broader space applications platform. He emphasized the strategic logic of the pending Iridium acquisition, saying it would combine launch, satellite manufacturing and a real space applications business with recurring revenue and rare spectrum. He was upbeat about demand, contract wins, and Neutron progress, but also stressed that the company is balancing speed to first flight with the need to reach flight 10 quickly and avoid requalification work.
Adam Spice focused on the financial quality of the quarter and the tradeoffs behind the numbers. He highlighted that revenue, gross margin and adjusted EBITDA all beat guidance, while Space Systems growth and backlog strength provided diversification beyond the inherently lumpy launch business. He also noted elevated cash use from Neutron tail production, infrastructure, and Mynaric supply chain replenishment, but said the quarter ended with roughly $2.4 billion in liquidity after $1.08 billion from the ATM equity offering, and that the company remains in a strong position to fund organic growth and acquisitions.
Analysts focused heavily on Neutron cadence, pricing, and whether demand will surge after first flight. Management said the key milestone is not just flight 1 but getting to flight 10 quickly, reiterated a 1, 3, 5 ramp concept, and said it sees more upside than downside on launch ASPs, including Neutron’s $50 million to $55 million target. Questions on Iridium centered on how Rocket Lab will accelerate growth and what the combination unlocks; management said the deal adds mission-critical constellation capability, strengthens its government and commercial toolkit, and opens up growth in PNT, IoT, direct-to-device, and other services. Analysts also asked about GHOST, HASTE pricing, and free cash flow; management said GHOST was customer-driven for mobile launch needs, HASTE pricing should stay consistent and could improve with rising demand, and free cash flow should remain pressured until after Neutron’s first successful test flight.
Rocket Lab is showing strong commercial momentum, with record quarterly revenue, a backlog of about $2.36 billion, and more than $1 billion of new contracts signed across the quarter and post-quarter period. Management also sees a larger strategic opportunity ahead through Iridium, which it says would add recurring applications revenue, spectrum, and a self-launching, vertically integrated business model.
The main risk remains execution on Neutron, where management said the window for an end-of-year launch is narrowing and cash burn will stay elevated through development, tail production and infrastructure buildout. The business also remains mix-sensitive, with launch revenue moving around based on accounting timing and Space Systems margins expected to fluctuate by product mix, while the Iridium deal is still pending and not expected to close until mid-2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.0%
- Shares Outstanding
- 598.46M
- Float Shares
- 556.86M
of shares held by institutions
1,220 13F filers
Buy/sell ratio 0.25. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 47.42M | ▲ 5.61M |
| Blackrock, Inc. | 40.58M | ▲ 2.59M |
| Vanguard Portfolio Management LLC | 27.12M | ▲ 1.38M |
| Vanguard Capital Management LLC | 25.30M | ▲ 1.01M |
| Invesco Ltd. | 18.34M | ▲ 14.75M |
| State Street Corp | 14.44M | ▲ 517.32K |
| Jpmorgan Chase & Co | 13.81M | ▲ 3.13M |
| Geode Capital Management, LLC | 10.50M | ▼ 67.65K |
| Baillie Gifford & Co | 10.38M | ▼ 8.04M |
| Capital World Investors | 7.37M | ▲ 128.33K |
| Morgan Stanley | 6.90M | ▲ 1.51M |
| Goldman Sachs Group Inc | 5.56M | ▲ 3.00M |
Held by 1,234 ETFs
Biggest fund positions in RKLB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Spice Adam C. | other | 140,157 |
| Oct 1, 26 | Spice Adam C. | other | 140,157 |
| Oct 1, 26 | Spice Adam C. | sell | 39,669 |
| Oct 1, 26 | Spice Adam C. | sell | 85,288 |
| Oct 1, 26 | Spice Adam C. | sell | 15,200 |
| Sep 2, 26 | Spice Adam C. | other | 140,157 |
| Sep 2, 26 | Spice Adam C. | other | 140,157 |
| Sep 2, 26 | Spice Adam C. | sell | 67,257 |
| Sep 2, 26 | Spice Adam C. | sell | 72,900 |
| Aug 31, 26 | Saintil Merline | other | 261,903 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RKLB coverage
Recent articles, reports, and earnings notes.

Rocket Lab USA (RKLB): Neutron Launch Is the Key Catalyst
Rocket Lab posted record Q2 revenue and a $2.36B backlog, but the stock still hinges on Neutron execution and margin expansion. The business is scaling fast, yet valuation remains demanding and profitability is still out of reach.

Rocket Lab USA, Inc. (RKLB) falls 10% on Neutron delay
Rocket Lab USA, Inc. (RKLB) falls 10% in after-hours trading after the company pushed Neutron’s first launch to 2027 because of manufacturing issues. The move follows a KeyBanc price-target cut and raises fresh questions about execution, even as Electron, HASTE, and space systems continue to support the business.

Astro Digital SPAC Merger: The Bull and Bear Case
Astro Digital is an aerospace company focused on modular satellite technology and mission support, and it’s going public via a merger with Proem Acquisition Corp. I (NASDAQ: PAAC). The deal is expected to close in Q1 2027, and the setup hinges on whether the company’s real customer traction can outweigh SPAC dilution and redemption risk.
Want a deeper read on RKLB?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Rocket Lab Corporation (RKLB) Outpaces Stock Market Gains: What You Should Know
zacks.com · Oct 26
The Big 3: VRT, NBIS, RKLB
youtube.com · Oct 26
Rocket Lab Delayed Neutron Over Voids in a Carbon-Composite Tank Dome. Here's Why That's Better News Than It Sounds.
fool.com · Oct 26
Rocket Lab Shed 25% Over 3 Months: 150% Returns Sure to Come According to This Wall Street Pro
247wallst.com · Oct 26
Rocket Lab Is Playing a Much Bigger Game Than Rocket Launches
247wallst.com · Oct 25
Rocket Lab Just Postponed Its Neutron Launch. Again.
fool.com · Oct 24
Should You Ignore the SpaceX Hype and Buy Rocket Lab Instead?
fool.com · Oct 24
Could Redwire Be the Next Rocket Lab?
fool.com · Oct 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 23, 2026 · Live quote · Not investment advice